Company Profile

Aspen Medisys LLC
Profile last edited on: 1/30/2024      CAGE: 5TMB2      UEI: SVMEMZ2LW6Z8

Business Identifier: Nanoparticle-based ablative and hyperthermic medical devices for treating cancer and other medical conditions
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

184 Cedar Hill Street
Marlborough, MA 01752
   (508) 380-7048
Location: Single
Congr. District: 03
County: Middlesex

Public Profile

Aspen MediSys was spun out of Aduro BioTech, Inc. with the mission of developing Magnetically Energized Thermotherapies for the treatment of cancer and other diseases. With close ties to Aspen Aerogels the firm offers nanoparticles, a cellular ablation device that operates at a size scale typical for drug delivery vehicles. As of December 2011 it was announced that Aspen Medisys, LLC would operate as a subsidiary of Consegna Group Limited (formerly the Helicon Group). A year later it was decided not to exercise their full options but instead to return the asset. The decision was based on the longer than expected development and commercialisation timeframe, higher than expected required investment, and weaker intellectual property position.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2010 1 NIH $200,000
Project Title: Tas::75 0849::Tas Magnetically Energized Nanoparticles For Treating Ovarian Cancer

Key People / Management

  Stephen Barry